465 related articles for article (PubMed ID: 15857703)
41. Effect of long-term blockade of CRF(1) receptors on exploratory behaviour, monoamines and transcription factor AP-2.
Mällo T; Berggård C; Eller M; Damberg M; Oreland L; Harro J
Pharmacol Biochem Behav; 2004 Apr; 77(4):855-65. PubMed ID: 15099932
[TBL] [Abstract][Full Text] [Related]
42. A single exposure to novelty differentially affects the accumbal dopaminergic system of apomorphine-susceptible and apomorphine-unsusceptible rats.
van der Elst MC; Verheij MM; Roubos EW; Ellenbroek BA; Veening JG; Cools AR
Life Sci; 2005 Feb; 76(12):1391-406. PubMed ID: 15670618
[TBL] [Abstract][Full Text] [Related]
43. Facilitation of dopamine-mediated locomotor activity in adult rats following cholinergic denervation.
Mattsson A; Ogren SO; Olson L
Exp Neurol; 2002 Mar; 174(1):96-108. PubMed ID: 11869038
[TBL] [Abstract][Full Text] [Related]
44. Neonatal administration of N-omega-nitro-L-arginine induces permanent decrease in NO levels and hyperresponsiveness to locomotor activity by D-amphetamine in postpubertal rats.
Morales-Medina JC; Mejorada A; Romero-Curiel A; Aguilar-Alonso P; León-Chávez BA; Gamboa C; Quirion R; Flores G
Neuropharmacology; 2008 Dec; 55(8):1313-20. PubMed ID: 18790702
[TBL] [Abstract][Full Text] [Related]
45. Partial denervation of the locus coeruleus projections by treatment with the selective neurotoxin DSP-4 potentiates the long-term effect of parachloroamphetamine on 5-hydroxytryptamine metabolism in the rat.
Eller M; Harro J
Neurosci Lett; 2002 Mar; 322(1):53-6. PubMed ID: 11958842
[TBL] [Abstract][Full Text] [Related]
46. Morphine sex-dependently induced place conditioning in adult Wistar rats.
Karami M; Zarrindast MR
Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
[TBL] [Abstract][Full Text] [Related]
47. Novelty-oriented behavior in the rat after selective damage of locus coeruleus projections by DSP-4, a new noradrenergic neurotoxin.
Delini-Stula A; Mogilnicka E; Hunn C; Dooley DJ
Pharmacol Biochem Behav; 1984 Apr; 20(4):613-8. PubMed ID: 6728877
[TBL] [Abstract][Full Text] [Related]
48. Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor.
Izzo E; Sanna PP; Koob GF
Pharmacol Biochem Behav; 2005 Aug; 81(4):701-8. PubMed ID: 16005056
[TBL] [Abstract][Full Text] [Related]
49. Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats.
Srinivasan J; Schmidt WJ
Eur J Neurosci; 2003 Jun; 17(12):2586-92. PubMed ID: 12823465
[TBL] [Abstract][Full Text] [Related]
50. Effect of repeated treatment with mirtazapine on the central dopaminergic D2/D3 receptors.
Rogóz Z; Wróbel A; Dlaboga D; Dziedzicka-Wasylewska M
Pol J Pharmacol; 2002; 54(4):381-9. PubMed ID: 12523492
[TBL] [Abstract][Full Text] [Related]
51. [The dynamic behavioral changes in rats after destruction of the locus coeruleus].
Oknina NB
Zh Vyssh Nerv Deiat Im I P Pavlova; 1991; 41(3):543-50. PubMed ID: 1656638
[TBL] [Abstract][Full Text] [Related]
52. Individual differences in novelty- and cocaine-induced locomotor activity as predictors of food-reinforced operant behavior in two outbred rat strains.
Gulley JM
Pharmacol Biochem Behav; 2007 Apr; 86(4):749-57. PubMed ID: 17408729
[TBL] [Abstract][Full Text] [Related]
53. Central noradrenergic lesion induced by DSP-4 impairs the acquisition of avoidance reactions and prevents molecular changes in the amygdala.
Radwanska K; Nikolaev E; Kaczmarek L
Neurobiol Learn Mem; 2010 Oct; 94(3):303-11. PubMed ID: 20650329
[TBL] [Abstract][Full Text] [Related]
54. Amphetamine-induced hyperlocomotion in rats: Hippocampal modulation of the nucleus accumbens.
White IM; Whitaker C; White W
Hippocampus; 2006; 16(7):596-603. PubMed ID: 16763995
[TBL] [Abstract][Full Text] [Related]
55. Phosphodiesterase 10A inhibition modulates the sensitivity of the mesolimbic dopaminergic system to D-amphetamine: involvement of the D1-regulated feedback control of midbrain dopamine neurons.
Sotty F; Montezinho LP; Steiniger-Brach B; Nielsen J
J Neurochem; 2009 May; 109(3):766-75. PubMed ID: 19236563
[TBL] [Abstract][Full Text] [Related]
56. Prefrontal cortex and basolateral amygdala modulation of dopamine-mediated locomotion in the nucleus accumbens core.
Rouillon C; Abraini JH; David HN
Exp Neurol; 2008 Jul; 212(1):213-7. PubMed ID: 18501353
[TBL] [Abstract][Full Text] [Related]
57. Nitrous oxide and xenon prevent amphetamine-induced carrier-mediated dopamine release in a memantine-like fashion and protect against behavioral sensitization.
David HN; Ansseau M; Lemaire M; Abraini JH
Biol Psychiatry; 2006 Jul; 60(1):49-57. PubMed ID: 16427030
[TBL] [Abstract][Full Text] [Related]
58. Differences in behavioural effects of amphetamine and dopamine-related gene expression in wild-type and homozygous CCK2 receptor deficient mice.
Rünkorg K; Värv S; Matsui T; Kõks S; Vasar E
Neurosci Lett; 2006 Oct; 406(1-2):17-22. PubMed ID: 16916582
[TBL] [Abstract][Full Text] [Related]
59. Descriptive and functional neuroanatomy of locus coeruleus-noradrenaline-containing neurons involvement in bradykinin-induced antinociception on principal sensory trigeminal nucleus.
Couto LB; Moroni CR; dos Reis Ferreira CM; Elias-Filho DH; Parada CA; Pelá IR; Coimbra NC
J Chem Neuroanat; 2006 Aug; 32(1):28-45. PubMed ID: 16678997
[TBL] [Abstract][Full Text] [Related]
60. Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies.
Ahmad M; Yousuf S; Khan MB; Hoda MN; Ahmad AS; Ansari MA; Ishrat T; Agrawal AK; Islam F
Pharmacol Biochem Behav; 2006 Jan; 83(1):150-60. PubMed ID: 16500697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
